MYRISTYLATION OF THE HEPATITIS-B VIRUS LARGE SURFACE PROTEIN IS ESSENTIAL FOR VIRAL INFECTIVITY

被引:154
|
作者
GRIPON, P
LESEYEC, J
RUMIN, S
GUGUENGUILLOUZO, C
机构
[1] Unité de Recherche Hépatologique U 49, Institut National de la Santé et de la Recherche Médicale, Hôpital de Pontchaillou, 35033, Rennes Cedex, rue Henri le Guillou
关键词
D O I
10.1006/viro.1995.0002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The hepatitis B Virus (HBV) envelope contains equimolar amounts of three viral proteins: the major (S), middle, and large (L) polypeptides. Their roles in the adsorption and penetration of the virus have not yet been elucidated. We have used a highly efficient in vitro model that permits reproducible HBV infection to investigate whether N-myristylation, a posttranslational modification of the L protein, was essential for viral infectivity. A point mutation abolishing myristylation was introduced into the HBV genome. Mutant virions were produced by transfecting viral DNA into hepatoma cells and their infectivity was evaluated on primary human hepatocyte cultures. No difference between mutant and wild-type viral RNA production could be observed. Furthermore, intermediate DNA replicative forms were observed in transfected cells demonstrating replication competence of mutant viral genomes. In addition, complete Virions were produced in the cell supernatant However, we found that mutant viral particles contained viral DNA with a reduced mean size, probably corresponding to a larger single-stranded region in the relaxed circular DNA form. We have evidenced the presence of pre-Si, pre-SP, and S epitopes at the outer surface of these virions by using immunoprecipitation with specific monoclonal antibodies. This result confirmed that mutant viruses were normally assembled. By contrast, myristylation-defective mutants completely lost their infectivity for human hepatocytes in primary cultures as shown by the absence of HBs antigen production and viral intermediate replicative forms in hepatocytes. In conclusion, the myristylation of the L protein is not required for the production of Dane-like particles but it is absolutely necessary for HBV infectivity. (C) 1995 Academic Press, Inc.
引用
收藏
页码:292 / 299
页数:8
相关论文
共 50 条
  • [21] VIRAL-HEPATITIS - AGENTS (HEPATITIS-B VIRUS) - DISCUSSION
    TAYLOR, PE
    HIRSCHMAN, SZ
    MAGNIUS, LO
    SHERLOCK, S
    NEURATH, AR
    TREPO, C
    GORDON, I
    KABAT, EA
    SCHUURS, A
    MELNICK, JL
    HOLLAND, PV
    NISHIOKA, K
    HOOFNAGLE
    GOLDFIELD
    HARNOIS, M
    HADZIYANNIS, SJ
    JOHNSON, A
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1975, 270 (01): : 205 - 209
  • [22] INHIBITION OF VIRAL REPLICATION BY MUTANTS OF THE DUCK HEPATITIS-B VIRUS CORE PROTEIN
    VONWEIZSACKER, F
    WIELAND, S
    BLUM, HE
    HEPATOLOGY, 1995, 22 (04) : 648 - 648
  • [23] CYS RESIDUES OF THE HEPATITIS-B VIRUS CAPSID PROTEIN ARE NOT ESSENTIAL FOR THE ASSEMBLY OF VIRAL CORE PARTICLES BUT CAN INFLUENCE THEIR STABILITY
    ZHOU, SL
    STANDRING, DN
    JOURNAL OF VIROLOGY, 1992, 66 (09) : 5393 - 5398
  • [24] HEPATITIS-B E-ANTIGEN TITERS FOR EVALUATING INFECTIVITY DURING HEPATITIS-B VIRUS-INFECTION
    LINDENSCHMIDT, EG
    GRANATO, CFH
    SALEFSKY, C
    LAUFS, R
    HENNING, H
    KLINISCHE WOCHENSCHRIFT, 1984, 62 (05): : 231 - 237
  • [25] STUDIES ON INTRAHEPATIC HEPATITIS-B VIRUS-DNA IN 98 VIRAL HEPATITIS-B PATIENTS
    WEN, YM
    LIU, HJ
    CHEN, HZ
    HUANG, YX
    HU, DC
    DUAN, SC
    WU, XH
    XU, HF
    CHINESE MEDICAL JOURNAL, 1986, 99 (11) : 861 - 865
  • [26] HEPATITIS-B (SURFACE) ANTIGEN AND VIRAL-HEPATITIS IN FAMILY CONTACTS OF ACUTE HEPATITIS-B PATIENTS
    FARNIK, J
    BERANOVA, I
    VILIM, V
    DBALA, D
    VESELY, V
    JINDRA, J
    ZAKOVA, M
    ZENTRALBLATT FUR BAKTERIOLOGIE MIKROBIOLOGIE UND HYGIENE SERIES A-MEDICAL MICROBIOLOGY INFECTIOUS DISEASES VIROLOGY PARASITOLOGY, 1976, 236 (2-3): : 199 - 204
  • [27] ESSENTIAL MIXED CRYOGLOBULINEMIA (EMC) AND HEPATITIS-B VIRUS
    RUSCONI, S
    GALLI, M
    FASEB JOURNAL, 1992, 6 (05): : A1902 - A1902
  • [28] THE RELATIONSHIP BETWEEN INFECTIVITY OF SERUM FROM HEPATITIS-B VIRUS CARRIERS, ANTIVIRAL THERAPY, AND INTEGRATED HEPATITIS-B VIRUS-DNA
    SHAFRITZ, DA
    ARIAS, IM
    HEPATOLOGY, 1982, 2 (01) : 106 - 107
  • [29] INFECTIVITY OF MEDICAL STAFF FOR HEPATITIS-B
    HOFMANN, H
    TUMA, W
    HEINZ, FX
    FRISCHNIGGEMEYER, W
    KUNZ, C
    INFECTION, 1988, 16 (03) : 171 - 174
  • [30] MOLECULAR HYDRIDIZATION METHODOLOGY A SENSITIVE INDICATOR OF HEPATITIS-B VIRUS INFECTIVITY
    FEINMAN, SV
    GUHA, A
    BRADLEY, DW
    SOOKNANAN, R
    BOND, W
    BERRIS, B
    MAYNARD, JM
    GASTROENTEROLOGY, 1983, 84 (05) : 1371 - 1371